HeraMED Limited
(ASX:HMD)

HeraMED’s (ASX:HMD) pre-natal care products work in tandem with practitioner care to provide a holistic care management program.

Latest Article

HeraMed to Spring-Board German Pre Natal Market Entry by Partnering with Telehealth Provider Kinderheldin

HeraMed to Spring-Board German Pre Natal Market Entry by Partnering with Telehealth Provider Kinderheldin

HeraMED (ASX:HMD) has signed an agreement with Kinderheldin to add online midwifery service to be offered as HeraBEAT PLUS in Germany.

Related Articles

ASX MedTech Transforming the US$50B Women’s Health Market

ASX MedTech Transforming the US$50B Women’s Health Market

HeraMED (ASX:HMD) has a target market of 2 million pregnancies in 2020, 6 million in 2021 and 45 million in 2022.

Thanks for subscribing!

X